Proficio Capital Partners LLC Takes $5.64 Million Position in DaVita Inc. (NYSE:DVA)

Proficio Capital Partners LLC bought a new stake in DaVita Inc. (NYSE:DVA) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 37,687 shares of the company’s stock, valued at approximately $5,636,000.

Other hedge funds have also bought and sold shares of the company. Transcendent Capital Group LLC bought a new stake in DaVita in the third quarter valued at approximately $25,000. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth approximately $60,000. Venturi Wealth Management LLC raised its stake in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc lifted its holdings in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. boosted its position in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after purchasing an additional 131 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DVA has been the subject of a number of research reports. Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita currently has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Price Performance

Shares of DaVita stock opened at $142.82 on Tuesday. The company has a 50-day simple moving average of $160.45 and a two-hundred day simple moving average of $158.18. DaVita Inc. has a twelve month low of $124.78 and a twelve month high of $179.60. The stock has a market capitalization of $11.43 billion, a price-to-earnings ratio of 13.30, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.